- Home
- ENTX vs CGTL Comparison
ENTX vs CGTL Comparison
Compare ENTX & CGTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- CGTL
- Stock Information
- Founded
- ENTX 2010
- CGTL 2016
- Country
- ENTX Israel
- CGTL Hong Kong
- Employees
- ENTX N/A
- CGTL N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- CGTL
- Sector
- ENTX Health Care
- CGTL
- Exchange
- ENTX Nasdaq
- CGTL NYSE
- Market Cap
- ENTX 69.6M
- CGTL 70.3M
- IPO Year
- ENTX 2018
- CGTL 2024
- Fundamental
- Price
- ENTX $1.79
- CGTL $5.62
- Analyst Decision
- ENTX Strong Buy
- CGTL
- Analyst Count
- ENTX 1
- CGTL 0
- Target Price
- ENTX $10.00
- CGTL N/A
- AVG Volume (30 Days)
- ENTX 30.9K
- CGTL 628.1K
- Earning Date
- ENTX 05-09-2025
- CGTL 05-15-2025
- Dividend Yield
- ENTX N/A
- CGTL N/A
- EPS Growth
- ENTX N/A
- CGTL 35.72
- EPS
- ENTX N/A
- CGTL 0.21
- Revenue
- ENTX $181,000.00
- CGTL $35,611,761.00
- Revenue This Year
- ENTX N/A
- CGTL N/A
- Revenue Next Year
- ENTX N/A
- CGTL N/A
- P/E Ratio
- ENTX N/A
- CGTL $26.25
- Revenue Growth
- ENTX N/A
- CGTL N/A
- 52 Week Low
- ENTX $1.41
- CGTL $2.80
- 52 Week High
- ENTX $2.79
- CGTL $10.59
- Technical
- Relative Strength Index (RSI)
- ENTX 49.59
- CGTL N/A
- Support Level
- ENTX $1.50
- CGTL N/A
- Resistance Level
- ENTX $1.84
- CGTL N/A
- Average True Range (ATR)
- ENTX 0.11
- CGTL 0.00
- MACD
- ENTX 0.03
- CGTL 0.00
- Stochastic Oscillator
- ENTX 85.50
- CGTL 0.00
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED
Creative Global Technology Holdings Ltd conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.